-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Dianthus Therapeutics, Inc. /DE/ quarterly/annual Operating Income (Loss) history and growth rate from 2016 to 2023.
- Dianthus Therapeutics, Inc. /DE/ Operating Income (Loss) for the quarter ending March 31, 2024 was -$17.8 M, a 132% decline year-over-year.
- Dianthus Therapeutics, Inc. /DE/ Operating Income (Loss) for the twelve months ending March 31, 2024 was -$58.3 M, a 330% decline year-over-year.
- Dianthus Therapeutics, Inc. /DE/ annual Operating Income (Loss) for 2023 was -$48.2 M, a 62.2% decline from 2022.
- Dianthus Therapeutics, Inc. /DE/ annual Operating Income (Loss) for 2022 was -$29.7 M, a 127% decline from 2021.
- Dianthus Therapeutics, Inc. /DE/ annual Operating Income (Loss) for 2021 was -$13.1 M, a 83.4% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)